InfuSystem Holdings

INFU · NYSE American

$14.23+$0.49 (+3.57%)TodayMarket closed ·
Prev close $13.74

About INFU

InfuSystem Holdings, Inc. engages in the provision of healthcare services. The company is headquartered in Rochester Hills, Michigan and currently employs 461 full-time employees. The company went IPO on 2006-06-15. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segment’s core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.

Employees
467
Headquarters
Rochester Hills, Michigan
Listed
Jun 15, 2006
Sector
Health Care
Industry
Health Care Providers & Services

INFU key statistics

Market cap
283.42M
Price-earnings ratio
34.35
Dividend yield
—
Average volume
113.63K
Volume
116.60K
Open price
$13.77
High today
$14.28
Low today
$13.77
52 Week high
$14.02
52 Week low
$7.29

InfuSystem Holdings (INFU) at a glance

As of Oct 20, 2026, InfuSystem Holdings (INFU) shares are priced at $14.23, giving the company a market cap of 283.42M and a price-to-earnings ratio of 34.35.

Today the stock has traded between $13.77 and $14.28. The current price is 3.3% above the day's low and 0.4% below its high.

Volume so far is 116.60K shares, in line with the average of 113.63K shares a day.

Over the past year InfuSystem Holdings has ranged from $7.29 to $14.02, and now sits 103% of the way up that range.

InfuSystem Holdings met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported $0.15 per share against an estimate of $0.1071.

The average analyst price target is $17.17, 20.7% above the current price, from 2 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 2 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 5 analystsAvg $17.17
Low
$15.15
Now
$14.23
High
$18.90

INFU earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 7 of the last 8 quarters, by 69.1% on average.

  1. Q3 FY24: reported $0.08 per share against an estimate of $0.0645
  2. Q4 FY24: reported $0.04 per share against an estimate of $0.077
  3. Q1 FY25: reported -$0.01 per share against an estimate of -$0.0408
  4. Q2 FY25: reported $0.12 per share against an estimate of $0.0367
  5. Q3 FY25: reported $0.11 per share against an estimate of $0.0816
  6. Q4 FY25: reported $0.10 per share against an estimate of $0.0738
  7. Q1 FY26: reported $0.05 per share against an estimate of $0.0341
  8. Q2 FY26: reported $0.15 per share against an estimate of $0.1071

INFU news

  • Press releaseBusiness Wire

    InfuSystem to Host Investor Webcast on September 24, 2026

  • 12 Health Care Stocks Moving In Tuesday's Intraday Session

  • Press releaseBusiness Wire

    InfuSystem Announces Financial Results for Second Quarter 2026

  • Press releaseBusiness Wire

    InfuSystem to Report Second Quarter 2026 Financial Results on August 4, 2026

  • Press releaseBusiness Wire

    InfuSystem Announces $20 Million Stock Repurchase Program

  • Press releaseBusiness Wire

    InfuSystem Announces Financial Results for First Quarter 2026

  • Press releaseBusiness Wire

    InfuSystem to Report First Quarter 2026 Financial Results on May 7, 2026

  • Press releaseBusiness Wire

    InfuSystem to Participate at 38th Annual ROTH Conference on March 23, 2026

Similar companies

Companies in the same industry as InfuSystem Holdings

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.